All stock lists
Drägerwerk AG & Co. KGaA (Deutsche Börse:DRW3.DE)
DE · Delayed Price · Currency is EUR
Also listed: DRWKFHealthcare · Medical - Devices
102.40+1.80 (+1.79%)
Insider Score
––Not scored
DRW3.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From DRW3.DE’s reported statements · Q2 2026 (trailing 12 months)
Profitability12 / 20
Profitable, but on a thin margin.
- Revenue
- $3.57B
- Net income
- $171.3M
- Net margin
- 4.8%
Leverage18 / 20
Little or no net debt.
- Total debt
- $388.4M
- Cash
- $198.5M
- Net debt / EBITDA
- 0.46x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.87B
- Current liabilities
- $912.8M
- Current ratio
- 2.05
Cash generation14 / 20
The business funds itself from operations.
- Operating cash flow
- $280.9M
- Free cash flow
- $188.4M
- FCF margin
- 5.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 18.8M
- Share growth (1y)
- -0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DRW3.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 847.30 M | 755.87 M | 1.14 B | 833.27 M | 779.99 M | 730.26 M |
| Revenue Growth (YoY) | 8.63 % | 3.51 % | 5.82 % | 7.58 % | -0.60 % | -0.76 % |
| Cost of Revenue | 452.10 M | 406.06 M | 620.71 M | 453.15 M | 438.01 M | 395.66 M |
| Gross Profit | 395.20 M | 349.82 M | 517.67 M | 380.12 M | 341.97 M | 334.60 M |
| SG&A Expense | 265.49 M | 250.43 M | 281.82 M | 242.31 M | 240.65 M | 249.74 M |
| R&D Expense | 83.67 M | 79.83 M | 84.67 M | 79.64 M | 85.95 M | 83.56 M |
| Operating Expenses | 349.16 M | 330.27 M | 366.49 M | 321.94 M | 323.37 M | 332.93 M |
| Operating Income | 45.90 M | 19.55 M | 151.17 M | 58.18 M | 15.37 M | 1.67 M |
| Pretax Income | 42.04 M | 15.65 M | 148.94 M | 53.33 M | 16.24 M | -2.88 M |
| Tax Provision | 13.10 M | 4.39 M | 54.05 M | 17.41 M | 4.83 M | -1.00 M |
| Net Income | 29.52 M | 11.44 M | 94.65 M | 35.68 M | 11.26 M | -2.09 M |
| EPS (Basic) | 1.57 | 0.61 | 5.05 | 1.91 | 0.60 | -0.12 |
| EPS (Diluted) | 1.57 | 0.61 | 5.05 | 1.91 | 0.60 | -0.12 |
| Shares Outstanding | 18.76 M | 18.76 M | 18.75 M | 18.72 M | 18.77 M | 17.39 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.